Kronox Lab Sciences Limited
- Minimum Investment₹14,190
- Price Range₹129 - ₹136
- Issue Size₹130.15 Cr
- Lot Size110 shares
Proceeds of this IPO to be used for
To carry out the offer for sale of up to 95,70,000 equity shares by the promoter selling shareholders
To achieve the benefits of listing the equity shares on the stock exchanges
Strengths & Weaknesses of Kronox Lab Sciences Limited
Wide range of products
The company manufactures a broad range of high-purity specialty fine chemicals belonging to the family of citrates, carbonates, phosphates, acetates, sulfates, EDTA derivatives, chlorides, hydroxides, bromides, nitrites, and nitrates
Long standing relationships
The company has served more than 592 customers in the last three financial years and during the nine-month period ended December 31, 2023, of which 141 customers, amounting to 23.8% of total customers, placed repeat orders
High entry and exit barriers
The company manufactures and markets high-purity specialty fine chemicals, which involve multi-step production and purification processes, and the products are measured against established domestic and international standards and stringent specifications of customers
Zero debt company
The company has a track record of operations of over a decade and has a robust balance sheet and cash flow position. Its positive operating cash flows, coupled with a zero-debt position, enable it to fund strategic initiatives, pursue opportunities for growth, and better manage unanticipated cash flow variations
Dependent on few customers
The company's top 20 products contributed 60.5% and 70.6% of the revenue for 9MFY24 and FY23, respectively. Any change in demand for these products from one of those customers could significantly affect the revenues
Dependent on few pharma industry
The majority of sales of the company's products are concentrated in industries such as pharmaceuticals and laboratory testing. Any change in demand or changes in application or processes by the customers in these industries may lead to a loss of revenues and profits
Relatively small company
The size of the company is relatively small in terms of revenue from operations when compared with other industry players and listed peers. Furthermore, it has a negligible market share in the chemical industry
Financials
Earnings Per Share
No Data
Balance Sheet
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Total Current Assets | -- | |
Total Non-Current Assets | -- | |
Fixed assets | -- | |
Total assets | -- | |
Total Current Liabilities | -- | |
Total Non-Current Liabilities | -- | |
Total Capital Plus Liabilities | -- | |
Total Shareholder Funds | -- | |
Total Debt to Equity | -- |
Cash Flow
Particulars (In Cr) | Y/Y Change | |
---|---|---|
Cash from Operating Activity | -- | |
Cash from Financing Activities | -- | |
Cash from Investing Activities | -- | |
Net Cash Flow | -- |
About Kronox Lab Sciences Limited
- PromoterJogindersingh Jaswal
- PromoterKetan Ramani
- PromoterPritesh Ramani